180 likes | 343 Views
Addressing the Unmet Need in Nonalcoholic Steatohepatitis. NAFLD Hepatic Manifestation of Metabolic Syndrome a. NAFLD (cont) Hepatic Manifestation of Metabolic Syndrome a. NAFLD/NASH Closely Associated With Visceral Obesity, Insulin Resistance.
E N D
NAFLD/NASH Closely Associated With Visceral Obesity, Insulin Resistance
Pioglitazone vs PlaceboSignificant Improvement of Histologic Features and Insulin Sensitivity
11β-HSD1 Inhibitor RO5093151 Inhibits Adipocyte Differentiation
Galectin-3 Binding Drug GR-MD-02 Inhibits Hepatic Injury in Mouse Model
Obeticholic Acid Improves Insulin Sensitivity and Markers of Liver Injury
Incretin Mimetics and Analogs Aid Maintenance of Glucose Balance